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Abstract: BilE has been reported as a bile resistance determinant that plays an important role in
colonization of the gastrointestinal tract by Listeria monocytogenes, the causative agent of listeriosis.
The mechanism(s) by which BilE mediates bile resistance are unknown. BilE shares significant
sequence similarity with ATP-binding cassette (ABC) importers that contribute to virulence and
stress responses by importing quaternary ammonium compounds that act as compatible solutes.
Assays using related compounds have failed to demonstrate transport mediated by BilE. The putative
substrate-binding domain (SBD) of BilE was expressed in isolation and the crystal structure solved
at 1.5 Å. Although the overall fold is characteristic of SBDs, the binding site varies considerably
relative to the well-characterized homologs ProX from Archaeoglobus fulgidus and OpuBC and OpuCC
from Bacillus subtilis. This suggests that BilE may bind an as-yet unknown ligand. Elucidation of the
natural substrate of BilE could reveal a novel bile resistance mechanism.
Keywords: Listeria monocytogenes; ABC transporters; ABC importers; substrate-binding protein;
substrate-binding domain; bile resistance; lmo1421; lmo1422
1. Introduction
Listeria monocytogenes is a Gram-positive bacterium that causes listeriosis, a potentially fatal
disease which imposes a significant global burden [1]. Infection usually occurs via contaminated food,
in particular ready-to-eat varieties [2,3]. The success of Listeria monocytogenes as a food-borne pathogen
is aided by its ability to survive and grow in extreme conditions found both in food-preparation
environments and in the gastrointestinal tract e.g., at low temperatures (down to −0.4 ◦C), at high
salt concentrations (up to 10% w/v NaCl), or in the presence of bile [4–7]. Determining the molecular
mechanisms by which Listeria monocytogenes survives these stresses could help to understand and
control its proliferation and is thus of interest from a food safety and health perspective. It is also
relevant to the rational design of probiotic bacteria [8,9].
One of the major challenges to bacterial growth and survival in the gastrointestinal tract is
the presence of bile (for reviews, including mechanisms of toxicity and bacterial resistance, see
References [10–13]). Bile is a digestive secretion produced by the liver and stored and concentrated
in the gallbladder before being released into the lower intestine, where it aids in the emulsification
and solubilization of fats. This is achieved by bile acids (also referred to as bile salts or bile alcohols,
Figure S1), a class of amphipathic cholesterol-derived steroids, which are also potent antimicrobials
due to their activity against biological membranes [12,14]. Several bile resistance mechanisms have
been identified in Listeria monocytogenes and other bacteria including the expression of multidrug
resistance efflux pumps and modification of bile acids via the enzyme bile salt hydrolase [6,7,15–18].
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Listeria monocytogenes BilE is a putative ATP-binding cassette (ABC) transporter that promotes
bile tolerance in vitro and colonization of the gastrointestinal tract in vivo [15,16,18]. However,
the specific mechanism(s) by which it achieves this is unknown. There are many transporters known
to mediate bacterial stress responses and virulence through the uptake of compatible solutes, low
molecular weight osmolytes that can be accumulated to high concentrations without interfering with
cellular processes [19]. In Listeria monocytogenes, the ABC transporters Gbu and OpuC, which are
homologous to BilE, as well as the functionally related secondary transporter BetL, contribute to
osmo-, bile- and chill-tolerance by importing glycine betaine and carnitine [16,20–22]. Although
it was initially hypothesized that BilE (then called OpuD) was an additional compatible solute
transporter, it has since been demonstrated that it is unable to mediate transport of glycine betaine,
carnitine, or choline (a metabolic precursor of glycine betaine), and plays no role in osmo- or
chill-tolerance [18]. The observation that Listeria monocytogenes knockout cells accumulate lower
levels of the bile component chenodeoxycholic acid led to the description of BilE as a bile exclusion
system [18,23]. This is at odds with the similarity of BilE to Type I ABC importers, which are structurally
and evolutionarily distinct from ABC exporters [24,25].
The main aim of this study was to generate structural information on BilE in order to make
improved hypotheses about the mechanism(s) by which it mediates bile resistance. The soluble
C-terminal domain of BilEB was crystallized and confirmed to have a substrate-binding protein
fold belonging to structural subcluster F-III [26,27]. The characterized members of this group are
all associated with ABC importers and bind compatible solutes. Although amino acid residues
interacting directly with the substrate are largely conserved with characterized homologs, differences
in surrounding residues mean that the overall architecture of the binding site varies significantly.
2. Results and Discussion
2.1. Sequence Analysis
BilE is encoded by the genes lmo1421 and lmo1422 in a genetic arrangement similar to the OpuA
(BusA) system from Lactococcus lactis [28,29] (Figure 1A,C). The first gene in the operon encodes BilEA,
the nucleotide-binding domain (NBD). The second gene encodes BilEB, a fusion protein containing
both a transmembrane (TMD) domain and a substrate-binding domain (SBD). The predicted functional
transporter is a homodimer (Figure 1B). Although the architecture of BilE is similar to Lactococcus lactis
OpuA, the individual domains share more sequence similarity with the equivalent subunits from
Listeria monocytogenes OpuC [30], Bacillus subtilis OpuB and OpuC [31], and Archaeoglobus fulgidus
ProX [32,33] (Figure 1C). These are all Type I ABC importers that contribute to osmo- or thermotolerance
through the import of quaternary ammonium compounds (QACs) which act as compatible solutes
either directly (e.g., glycine betaine), or as metabolic precursors (e.g., choline).
Part of the justification for reclassifying BilE as a bile exporter was the identification of “bile
acid permease signature sequences” conserved between BilEA and the NBDs of bile salt exporters
Saccharomyces cerevisiae Ybt1 and mammalian ABCB11 [18]. We constructed an expanded sequence
alignment, which includes the NBDs OpuCA and GbuA from Listeria monocytogenes, and see no
evidence that BilEA shares unique sequence characteristics with the eukaryotic proteins (Figure 1D
and Figure S2).




Figure 1. (A) The genetic arrangement of BilE; (B) a schematic of the predicted functional transporter;
and (C) comparison to characterized homologs. Strain details and protein accession numbers are listed
in Table A1. Genes and proteins are color-coded based on the predicted function: nucleotide-binding
domains (NBDs), purple long dashes; transmembrane domains (TMDs), solid green; substrate-binding
domains (SBDs), orange short dashes. When two TMDs are present, values from the closest match are
reported. Numbers indicate the percentage sequence identity (similarity) between equivalent domains
based on pairwise alignments made with the program needle from EMBOSS (the European Molecular
Biology Open Software Suite) [34]. (D) An extract from a multiple sequence alignment of selected
NBDs. The region shown is the same as in Sleator et al. [18], but the alignment has been expanded
to include proteins from the Listeria monocytogenes Gbu and OpuC systems. Residues are shaded
according to percentage sequence identity. (E) Multiple sequence alignment of BilEB and the TMDs
from Listeria monocytogenes OpuC. Numbering is according to BilEB. Sequences are shaded according
to percentage sequence similarity. Bars above the alignment indicate transmembrane segments (TMSs)
predicted by TOPCONS [35] (light green) or by comparison to crystal structures of homologous ABC
importers (dark green). Lettering indicates the orientation of predicted TMSs relative to the cytoplasm
(out-to-in or in-to-out), which is in agreement between the two methods.
In the ABC transporters that have been crystallized, the fold of the TMD varies significantly
between importers and exporters [24]. The HHpred server [36], which is designed for remote protein
homology detection and structure prediction, was used to search the Protein Data Bank (PDB) with
residues 1–231 of BilEB as the query sequence. The top matches were to the permease subunits of
six different Type I ABC importers from bacteria and archaea (Table A2). The sequence alignment
produced by HHpred covers the five transmembrane segments (TMSs) that are conserved between all
of these structures and which, after dimerization, make up the core of the transporter. The predicted
positions of these TMSs in BilEB closely match topology predictions made using the TOPCONS
server [35] (Figure 1E). The additional sixth TMS, predicted by TOPCONS, would position the predicted
C-terminal SBD at the outer surface of the membrane where it could serve as receptor and bind ligands
for subsequent transport. A comparison of BilEB with OpuCB and OpuCD from Listeria monocytogenes
shows that the TMDs are similar in size, and that there is sequence similarity along the entire domain
(Figure 1E).
Based on sequence homology, the C-terminus of BilEB contains a substrate-binding domain (SBD)
belonging to substrate-binding protein (SBP) subcluster F-III [26,27]. All characterized members of this
cluster are part of an ABC transporter and bind QACs via cation–pi interactions. They can be further
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divided into two groups based on whether the quaternary ammonium of the substrate is coordinated
via three tryptophan residues (e.g., OpuAC from L. lactis [37] and ProX from Escherichia coli [38]) or
four tyrosines (e.g., ProX from Archaeoglobus fulgidus [33]). Interestingly, a sub-group also exists
which share their tertiary structure with the Lactococcus lactis OpuAC group (including tryptophan
residues of the binding site) but in whose primary sequence the N- and C-terminal halves are
swapped (e.g., OpuAC from Bacillus subtilis [39,40]). The sequence of BilEB is most similar to AfProX
(33% identity, 51% similarity), although one binding site tyrosine is substituted for a phenylalanine.
Figure 2 shows a multiple sequence alignment of BilEB, AfProX, and other selected homologs in
which these four tyrosine residues are conserved: OpuBC and OpuCC from Bacillus subtilis [31];
OpuCC from Listeria monocytogenes [30], Staphylococcus aureus [41], Pseudomonas aeruginosa and
Pseudomonas syringae [42]; OsmX (OpuCC) from Salmonella typhimurium [43,44]; and YehZ from
Escherichia coli [45]. The known ligands of these proteins include glycine betaine, proline betaine,
choline, acetylcholine, choline-O-sulfate, carnitine, and ectoine (Figure S3). Several other studied
homologs were excluded from this analysis: OpuCC from Pseudomonas syringae pv. syringae B728a [42],
because it is 97% identical to the included OpuCC from Pseudomonas syringae pv. syringae DC3000;
YehZ from Salmonella typhimurium [46], because it is 88% identical to EcYehZ and its substrate is
unknown; and ProX from Agrobacterium tumefaciens, because no data apart from crystal structures
(PDB ID 4NE4 and 4ND9) are available.
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Figure 2. Multiple sequence alignment of BilEB and selected substrate-binding protein homologs. 
For a full list of organism names and protein accession numbers, see Table A1. The alignment has 
been truncated at the N-terminus to exclude signal sequences and residues not visible in the 
crystallographic structures. Sequences are numbered according to the unprocessed form of the 
protein, unless this varies from numbering used in published studies in which case the numbering is 
consistent with the literature. Residues are shaded according to percentage sequence identity. The 
secondary structure of BilEBSBD is indicated above the alignment. Domain A is indicated in purple, 
domain B in green. Arrows indicate β-sheets; large loops indicate α-helices, small loops indicate 
310-helices (secondary structure assigned by DSSP [47]). Orange symbols below the alignment 
indicate amino acid residues involved in substrate binding either through caging the quaternary 
ammonium (closed circles) or forming salt bridges or hydrogen bonds (open circles). 
Figure 2. Multiple sequence alignme t of BilE and selected substrate-bin i r tein hom logs. For a
full list of organism names and protein accession numbers, see Table A1. The alignment has been
truncated at the N-terminus to exclude signal sequences and residues not visible in the crystallographic
structures. Sequences are numbered according to the unprocessed form of the protein, unless this
varies from numbering used in published studies in which case the numbering is consistent with the
literatur . Residues are shaded according to perc ntage sequence ide tity. The seco dary structure
of BilEBSBD is indicated above the alignment. Domain A is indicated in purple, domain B in green.
Arrows indicate β-sheets; large loops indicate α-helices, small loops indicate 310-helices (secondary
structure assigned by DSSP [47]). Orange symbols below the alignment indicate amino acid residues
involved in substrate binding either through caging the quaternary ammonium (closed circles) or
forming salt bridges or hydrogen bonds (open circles).
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2.2. Structure of the Putative Substrate-Binding Domain from BilEB
We were unable to measure any glycine betaine transport or osmoprotective activity when
BilE was expressed in Lactococcus lactis (data not shown). We decided to focus on the putative
substrate-binding domain (residues 231–504 of BilEB, hereafter referred to as BilEBSBD). BilEBSBD
was successfully expressed in Escherichia coli with a His-tag and purified from the soluble fraction
via affinity chromatography. The purified protein was analyzed by SEC-MALLS (size-exclusion
chromatography coupled to static light-scattering, differential refractive index, and UV absorbance
measurements) in order to determine its oligomeric state [48]. A single elution peak was observed with
an estimated molecular mass of 32.4 kDa (Figure S4). This is in good agreement with the molecular
mass of 33.4 kDa calculated using the ProtParam tool [49] and indicates that the isolated BilEBSBD is
monomeric in solution. Differential scanning calorimetry was used to screen for substrate binding, but no
significant changes in melting temperature were observed in the presence of glycine betaine, carnitine,
choline, proline, or cholate (5 µM of protein and up to 5 mM of ligand at pH 7.5; data not shown).
The X-ray structure of BilEBSBD was determined at a resolution of 1.5 Å and deposited in the PDB
under accession number 4Z7E (Table 1). Two protein molecules are present in the asymmetric unit but
they differ only slightly, with a root-mean-square deviation of atomic positions (RMSD) of 0.33 Å over
all atoms. Several areas of density were assigned to polyethylene glycol and propanoic acid from the
crystallization solution, but for the most part these are external to the protein and are not biologically
relevant. The exception is a molecule of propanoic acid in the putative binding site of BilEBSBD, which
will be discussed in the following section.




a, b, c (Å) 45.96, 62.87, 97.02
α, β, γ (◦) 90, 91.71, 90





Completeness (%) 96.0 (97.0)
Redundancy 1.9 (2.0)
Refinement
Resolution range (Å) 48.49–1.50 (1.52–1.50)
No. of reflections, working set 166,898 (5303)
No. of reflections, test set 8333 (280)
Rwork/Rfree 0.153/0.198
















1 Values in parentheses are for the highest-resolution shell.
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The overall fold of BilEBSBD consists of two globular α/β domains joined by a hinge formed
from two long flexible strands (Figure 3A). Each domain is comprised of a five-stranded β-sheet
surrounded by α-helices. This fold is characteristic of SBPs of subcluster F-III [26,27]. As expected
based on sequence similarity, a search for structural homologs in the PDB using the Dali server [50]
gave the best match as the open, unliganded structure of AfProX (PDB ID 1SW5, Table A3). The RMSD
is 1.7 Å over 267 aligned residues (out of a total of 270). Matches with Z-scores greater than 25 were
also returned for the structures of SaOpuCC, AtProX, BsOpuBC, BsOpuCC, and EcYehZ (Table A3).
Based on comparisons with AfProX and in keeping with the literature we have defined domain A as
containing the N- and C-terminus (residues 235–338 and residues 440–504) and domain B as containing
the central region of the protein (residues 339–439). The binding site of SBPs contains residues from
both domains, which trap the ligand by moving towards each other in what is often described as a
“Venus’s-flytrap” mechanism [51] (Figure 3B). A comparison of the BilEBSBD structure with structural
homologs shows that it was crystallized in the open conformation.
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Propanoic acid and glycine betaine are colored white. Bound water molecules are shown as red 
spheres. Residues forming a cage around the quaternary ammonium are dark gold except for the 
position corresponding to Phe292 in BilEBSBD, which is pale gold. Residues corresponding to Gly243 
and Pro246 in BilEBSBD are colored pale blue. The grey mesh in (C) is an omit Fo-Fc electron density 
map contoured at 2.0 σ. Dashed lines indicate hydrogen bonds or salt bridges. (E,F) The same view as 
(C,D), respectively, with the proteins shown in surface representation and domain B omitted for 
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Figure 3. Comparison f the crystal structures of BilEBSBD and A. fulgidus ProX: (A, ) BilEBSBD and
AfProX in cartoon representation with domain of each protein in purple and domain B in green.
Both the open and closed conformations of ProX are shown (PDB ID 1SW5 and 1SW2, respectively) in
order to demonstrate the movement of domains during substrate binding. (C,D) Binding site residues
from domain A of (C) BilEBSBD and (D) AfProX (PDB ID 1SW5). Amino acid residues and ligands are
shown in stick representation with oxygens colored red and nitrogens colored blue. Propanoic acid
and glycine betaine are colored white. Bound water molecules are shown as red spheres. Residues
forming a cage around the quaternary ammonium are dark gold except for the position corresponding
to Phe292 in BilEBSBD, which is pale gold. Residues corresponding to Gly243 and Pro246 in BilEBSBD
are colored pale blue. The grey mesh in (C) is an omit Fo-Fc electron density map contoured at 2.0 σ.
Dashed lines indicat hydrogen bonds or salt bridges. (E,F) The same view as (C,D), respectively, with
the proteins shown in surface representation and domain B omitted for clarity. Images were prepared
in PyMOL [52].
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2.3. Binding Site Comparisons
AfProX, BsOpuBC and BsOpuCC have all been crystallized in complex with their natural
substrates [33,53,54]. In each case the quaternary ammonium group sits in a cage whose sides are
formed by four Tyr residues and whose base is the main chain of either an Asp or Asn. The other
part of the substrate is coordinated by interactions with specific side-chains. In the case of AfProX,
the cage is formed by Tyr63, Tyr111, Tyr190, Tyr214, and Asp109, while the carboxylic tail of GB or PB
forms salt bridges with Lys13 and Arg149 (domain A and B, respectively) and a hydrogen bond with
Thr66 (domain A). These residues are conserved in BilEBSBD in both the primary sequence and the
crystallographic model (Figures 2 and 3C), except for the substitution of Phe292 for Tyr63.
Studies of AfProX suggest that residues of the substrate-binding site from domain A undergo
minimal conformational change between the open and closed forms of the protein [32,33]. Despite
the fact that BilEBSBD has only been crystallized in the open, unliganded conformation, we can still
make some comments about the putative binding site. A comparison of domain A from BilEBSBD
and AfProX show that the position of the binding site residues is largely conserved (Figure 3C,D).
The Phe292 side chain of BilEBSBD, however, is tilted into the putative binding site. The corresponding
residue in AfProX, Tyr63, forms hydrogen bonds with Glu17 and Gln18 [33] (Figure 3D). This Glu
residue is strictly conserved in characterized homologs (Figure 2) and appears to hydrogen bond with
the equivalent Tyr in all the available crystal structures. Phe292 is unable to form these interactions.
The positioning of Phe292, as well as the substitution of Phe15 and Gln18 from AfProX with the
less bulky Gly243 and Pro246 in BilEBSBD, results in a cavity on the face of domain A adjacent to the
putative binding site (Figure 3E). Within this cavity is a molecule of propanoic acid bound by stacking
interactions with Phe292 and hydrogen bonding with Tyr335. In chain B of the model, which contains
the best density for the propanoic acid, two water molecules can also be clearly seen within this
cavity. These are coordinated by hydrogen bonds with the propanoic acid, the main chain carboxyl of
Pro290, and the main chain amide of Lys241. No such cavity is seen on the domain A face of AfProX,
BsOpuBC or SaOpuCC (Figure 3F and Figure S5). BsOpuCC does have a larger binding site, but the
extra space is in a different position and is required in order to accommodate the larger substrate
carnitine. The structures of open, unliganded EcYehZ and AtProX, which both have an Asp and Gly
at the positions equivalent to Gly243 and Pro246, do show a cavity in the same position as BilEBSBD.
Although it is smaller, it is open to the bulk solvent and contains two water molecules.
The presence of Gly243 also has implications for stabilization of the closed state. In AfProX,
the position of the Tyr190 phenyl ring from domain B is stabilized by C–H . . . pi interactions with
Phe15. The structures of BsOpuBC and BsOpuCC suggest that similar interactions occur between
Tyr197/Tyr217 and Met21/Tyr41. The mutation of Met21 to Ala in OpuBC results in a three-fold increase
in the Kd for choline from 30 µM to 97 µM [53]. In the structure of BilEBSBD there are no nearby
residues that would be able to fulfill this role.
These differences in the structure of BilEBSBD suggest that its natural ligand could vary
significantly from those predicted based on sequence analysis. Unfortunately, the crystal structure
does not lead directly to possible alternatives. Bile acids, besides being even larger than the extra space
made available by the binding site cavity, do not make sense as an import substrate for a bile resistance
protein; for bile acid tolerance the molecules would have to exported rather than imported.
2.4. Conservation of BilEB
In order to determine if the structural features described here are unique to BilEB, we used
the UniRef50 database [55] to generate a list of sequences with significant similarity to BilEBSBD
[E-value of less than 0.0001 in a Basic Local Alignment Search Tool (BLAST) search] and less than 50%
pairwise sequence identity. Each sequence in the list thus represents a cluster of one or more original
sequences. Using AfProX as the query sequence resulted in a very similar list. We then excluded
sequences that did not contain either a Tyr, Phe or Trp residue at the four positions corresponding to
the binding site tyrosines of AfProX. Our final list of 198 sequences contains proteins with various
Crystals 2016, 6, 162 8 of 16
domain organizations including isolated SBPs as well as TMD-SBD, SBD-TMD and even SBD-SBD
fusions (Figure 4A, Supplementary File S1). Analysis with HHpred [36] suggests that these additional
C-terminal SBDs belong to structural subclusters F-IV or E-II, both of which contain SBPs that bind
amino acids and are associated with importers, channels or receptors [26,27]. We also identified
three SBPs and four TMD-SBD fusions which contain a sequence swap similar to OpuAC from
Bacillus subtilis [39,40] (Figure 4A).
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(inset) reference sequences. Reference sequences for clusters containing SBPs discussed in this paper
are shown in black. The reference sequence for the cluster containing PsOpuCC was removed during
an automated trimming step. Topology predictions made by TOPCONS [35] are shown in green
(TMSs) and purple (signal sequences). Orange indicates an additional SBP fold as predicted by
HHpred [36]. Wher sequences we e manually alt red to reflect a change in the primary sequence
compared to the p edicted tertiary structure (as described for Bacillus subtilis OpuAC), th shifted
C-terminal portion is shown in blue. Dashed outlines indicate sequences containing a Gly residue at the
position corresponding to Gly243 of BilEB. The histogram below the main alignment shows sequence
conservation. (B) Frequency plots showing the distribution of amino acids at corresponding positions
of each alignment. Numbering shown is according to BilEB. (C) The ConSurf server [56] was used to
map the conservation of each alignment onto the BilEBSBD structure. A molecule with the same color
scheme as Figure 3 is included for clarity. Domains A and B are shown in dark grey and light grey,
respectively. Residues predicted to form a cage ar und e quaternary ammonium are d rk gold except
for Phe292, which is pale gold. Gly243 and Pro246 re colored pale blue. (D) Phylogenetic distribution
of the sequences represented in each alignment. Values shown are the number of unique organisms
in each taxa which have sequences in the UniRef50 (left column) or UniRef90 (right column) clusters.
Images were prepared using Jalview [57], PyMOL [52], and iTOL [58].
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The most common residues at the position corresponding to Gly243 of BilEB are Phe (61.3%),
Tyr (9.4%), Asp (7.3%), Gly (6.8%), Met (4.7%), Thr (3.1%), and Ser (2.1%) (Figure 4B). Each of these
alternatives, except for Tyr, is represented in the characterized QAC-binding homologs (Figure 2).
Expanding the 13 reference sequences containing a Gly at this position to the UniRef90 database (a
maximum of 90% pairwise sequence identity) returned 399 sequences, all of which are TMD-SBD
fusions (Figure 4A, inset, and Supplementary File S2). Gly243 (98.8%), Pro246 (99.0%) and Phe292 (94.5%)
are all highly conserved (Figure 4B). Mapping the conservation from each multiple sequence alignment
onto the BilEBSBD crystallographic model shows that conserved residues are clustered around the
putative binding site (Figure 4C). Within the Gly243 subgroup the residues lining the cavity on the face
of domain A are also conserved. This suggests that BilE is a member of a conserved subgroup with
unknown transport specificity.
The initial list of UniRef50 reference sequences represents genes from a wide range of taxa,
including eukaryotes, archaea and bacteria (Figure 4D). The highest number of sequences is found
within the class Bacilli. The UniRef90 Gly243 subgroup shows a similar phylogenetic distribution,
although it is even more heavily biased towards the Bacilli. A closer look suggests that BilE homologs
are widespread within genera known to contribute to the human microbiome including Bacillus,
Enterococcus, Lactobacillus, Neisseria, Staphylococcus, and Streptococcus, as well as in the genus Lactococcus.
3. Materials and Methods
3.1. Cloning, Expression and Purification
The isolated substrate-binding domain of BilE was expressed in Escherichia coli MC1061 with
an N-terminal tag consisting of 10 histidine residues and a tobacco etch virus (TEV) protease
cleavage site (for the full amino acid sequence see Appendix B). To construct the expression plasmid,
amino acid residues 231–504 of BilEB were amplified by polymerase chain reaction using the
oligonucleotides 5′-ATGGTGAGAA TTTATATTTT CAAGGTTCGG ATAAAAAGGA AATTACAATT
GCTGGTAAAT TAG-3′ and 5′-TGGGAGGGTG GGATTTTCAT TATTTAATAA TACCTTGATC
TTTCAAATAG TCTTTGGCAA CTG-3′ and cloned into pBADnLIC as described by Geertsma and
Poolman [59]. The resulting plasmid, pBAD-lmo1422SBDnLIC, was confirmed by sequencing the
entire open reading frame.
For expression, Escherichia coli containing pBAD-lmo1422SBDnLIC were inoculated into LB media
containing 100 µg/mL ampicillin and grown at 37 ◦C with shaking to an OD660 of 0.7. L-Arabinose
was added to induce expression (final concentration 5 × 10−3% w/v) and the cultures incubated for
2 h at 25 ◦C with shaking. Cells were harvested by centrifugation and resuspended in Buffer A (50 mM
potassium phosphate pH 7.5, 200 mM NaCl) with 5 mM MgSO4 and 100 µg/mL DNase. Cells were
disrupted by a single pass through a cell disruptor (Constant Systems Ltd, Daventry, UK) at 25,000 psi
and stored at −80 ◦C before purification.
BilEBSBD was purified by Ni2+-affinity and size-exclusion chromatography using ÄKTA systems
(GE Healthcare Life Sciences, Eindhoven, The Netherlands). Disrupted cells were thawed on ice and
the insoluble fraction removed by ultracentrifugation (80,000 rpm, 4 ◦C, 20 min). The lysate was
diluted 3-fold in Buffer A, and imidazole added to a final concentration of 10 mM. The solution was
passed over a Ni2+-sepharose column (approximately 1 mL bed volume per mg wet weight cells)
which had been pre-equilibrated in Buffer B (20 mM Hepes pH 7.5, 200 mM NaCl) with 10 mM
imidazole. The column was washed with three volumes of Buffer B with 75 mM imidazole, and eluted
with Buffer C (20 mM Hepes pH 7.5, 150 mM NaCl) with 500 mM imidazole. Elution fractions were
collected directly into tubes containing 1/100 volumes of 0.5 M Na-EDTA (to give a final concentration
of 5 mM) before being pooled, diluted 2.5-fold in Buffer C, and concentrated using a Vivaspin column
(GE Healthcare Life Sciences, Eindhoven, The Netherlands) with a molecular weight cut-off of 10 kDa.
The concentrated sample was then passed over a Superdex 200 10/300 GL column (GE Healthcare Life
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Sciences, Eindhoven, The Netherlands) in Buffer C. Eluted fractions were again concentrated using a
Vivaspin column.
Determination of the molecular weight of purified BilEBSBD by SEC-MALLS was performed as
described previously [48], using a Superdex 200 10/300 GL column pre-equilibrated in Buffer C.
3.2. Crystallization
All crystallization experiments were performed at 4 ◦C. Initial crystallization trials were
carried out using a high-throughput crystallization robot (Mosquito, TTP Labtech, Melbourn,
UK), commercially available kits from Molecular Dimensions, and the sitting-drop vapor-diffusion
technique. BilEBSBD was found to crystallize in condition 25 from PACT premier (0.1 M PCTP (sodium
propionate, sodium cacodylate trihydrate, Bis-Tris propane) pH 4.0, 25% (w/v) PEG-1500). Further
crystallization trials were carried out using the hanging-drop vapor-diffusion method. The crystal
used to solve the structure was obtained by mixing equal volumes of BilEBSBD (20 mg/mL in Buffer C)
with the reservoir solution (0.1 M PCTP pH 4.25, 25% w/v PEG-1500). Cryo-buffer consisted of PACT
premier 25 with an additional 15% (w/v) PEG-1500.
3.3. Structure Determination and Refinement
X-ray diffraction data were collected at the X06SA (PXI) beamline at the SLS (Paul Scherrer
Institut, Villigen, Switzerland) and processed with the XDS package [60]. The structure was solved
by molecular replacement with the program Phaser [61] using the structure of open, unliganded
Archaeoglobus fulgidus ProX (PDB code 1SW5) as the search model. Refinement was performed with
REFMAC5 [62] and PHENIX [63], with additional manual adjustments made in Coot [64]. The data
and refinement statistics are listed in Table 1.
3.4. Sequence and Structure Analysis
Percent sequence identity values are from pairwise sequence alignments generated by the
EMBOSS needle program [34]. All multiple sequence alignments were made using Clustal Omega [65]
at the EMBL-EBI server [66]. Topology predictions were made using the TOPCONS server [35].
To generate a list of BilEBSBD homologs with lowered redundancy, a BLAST search was conducted
against the UniRef50 database (accessed 9 September 2016) [55] using residues 231–504 of BilEB as
the query sequence. Sequences less than 250 or more than 650 amino acids in length were discarded.
The resulting list was trimmed using MaxAlign [67], which removes sequences creating significant
gaps in a multiple sequence alignment. This is designed to remove truncated or incorrectly annotated
sequences, but in this case also removed several proteins that appear to have a sequence swap similar to
OpuAC of Bacillus subtilis [39,40]. These sequences were manually altered by removing the C-terminal
portion and inserting it immediately following the predicted signal sequence or final TMS, and they
were then added back to the list. Finally, any sequences that did not contain a Tyr, Phe, or Trp at the
four positions corresponding to the binding site Tyr residues of AfProX were discarded. The final
alignment contains 198 sequences of 267 to 650 amino acids in length. The members of each UniRef50
cluster whose representative sequence has a Gly at the position equivalent to Gly243 of BilEB (n = 13)
were gathered and reduced to 90% identity by mapping to the UniRef90 database. The same alignment
and trimming procedures were applied, yielding a multiple sequence alignment with 399 sequences of
500 to 597 amino acids in length.
4. Conclusions
The C-terminus of BilE has a distinctive SBP fold, which supports the classification of BilE as a
Type I ABC importer. Differences in the architecture of the binding site compared to characterized
homologs indicate that the transport substrate(s) of BilE may vary significantly from those previously
predicted (glycine betaine and other quaternary ammonium compounds which act as compatible
solutes). This would explain why no transport activity has been observed, and opens up the possible
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discovery of a novel mechanism of bile resistance. The crystal structure of BilEBSBD determined in
this study allows for the identification of possible candidate substrates via in silico methods such as
ligand docking.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4352/6/12/162/s1:
Figure S1: Chemical structures of the most abundant bile acids in humans; Figure S2: Multiple sequence
alignment of selected NBDs; Figure S3: Ligands of substrate-binding proteins homologous to BilEBSBD; Figure S4:
Determination of the oligomeric state of BilEBSBD; Figure S5: The binding site on the face of domain A; File S1:
Multiple sequence alignment of UniRef50 reference sequences; File S2: Multiple sequence alignment of UniRef90
reference sequences.
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Appendix A.
Table A1. Proteins used in this study for sequence- and structure-based analyses.
Organism 1 and Transporter Protein Subunits 2,3 and UniProtKB Accession Numbers
Archaeoglobus fulgidus VC16 (Af)
ProU [32,33]
ProX (SBD) ProV (NBD) ProW-2 (TMD) ProW-1 (TMD)
O29280 O29281 O29282 O29283
Bacillus subtilis 168 (Bs)
OpuB [31,53] OpuBA (NBD) OpuBB (TMD) OpuBC (SBD) OpuBD (TMD)
Q45460 Q45461 Q45462 P39775
OpuC [31,54] OpuCA (NBD) OpuCB (TMD) OpuCC (SBD) OpuCD (TMD)
O34992 O34878 O32243 O34742
Escherichia coli K-12 (Ec)
YehZYXW [45]
YehZ (SBD) YehY (TMD) YehX (NBD) YehW (TMD)
P33362 P33361 P33360 P33359
Lactococcus lactis subsp. lactis IL1403 (Ll)









GbuA (NBD) GbuB (TMD) GbuC (SBD)
Q7AP76 Q7AP75 Q8Y898
OpuC [30] OpuCA (NBD) OpuCB (TMD) OpuCC (SBD) OpuCD (TMD)
Q7AP65 Q7AP66 Q7AP67 Q7AP68
Pseudomonas aeruginosa PAO1 (Pa)
OpuC [42] OpuCD (TMD) OpuCC (SBD) OpuCB (TMD) OpuCA (NBD)
Q9HXC5 Q9HXC4 Q9HXC3 Q9HXC2
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Table A1. Cont.
Organism 1 and Transporter Protein Subunits 2,3 and UniProtKB Accession Numbers
Pseudomonas syringae pv. syringae B728a (Ps)
OpuC [42] OpuCD (TMD) OpuCC (SBD) OpuCB (TMD) OpuCA (NBD)
Q4ZNJ0 Q4ZNJ1 Q4ZNJ2 Q4ZNJ3
Salmonella typhimurium LT2 (St)
OsmU [43,44]
OsmY (TMD) OsmX (SBD) OsmW (TMD) OsmV (NBD)
Q8ZPK1 Q8ZPK2 Q8ZPK3 Q8ZPK4
Staphylococcus aureus Mu50 (Sa)
OpuC [41] OpuCA (NBD) OpuCB (TMD) OpuCC (SBD) OpuCD (TMD)
A0A0H3JT61 A0A0H3JTI8 A0A0H3K0Z1 A0A0H3JU54
1 Letters in parentheses are the two-letter code used in the main text and in figures; 2 Protein subunits are listed
in order of their position in the operon; 3 Letters in parentheses indicate domain type (NBD = nucleotide-binding,
TMD = transmembrane, SBD = substrate-binding).
Table A2. Top results (Prob 1 > 50) from searching the PDB using the HHpred server [36] with BilEB
(residues 1–231) as the query sequence.
PDB ID Transporter, Substrate, Organism Prob 1 E-Value Cols 2
2ONK_C ModB2C2A, molybdate, Archaeoglobus fulgidus [69] 99.9 6.60 × 10−24 209
3D31_C ModB2C2A, molybdate, Methanosarcina acetivorans [70] 99.9 6.70 × 10−24 207
3TUI_A MetNI, methionine, Escherichia coli [71] 99.9 1.90 × 10−23 201
4YMU_D At(QN)2, amino acids, Thermoanaerobacter tengcongensis [72] 99.9 4.10 × 10−23 211
4TQU_M AlgQ2M1M2SS, alginate, Sphingomonas sp. A1 [73] 99.9 6.20 × 10−23 209
3RLF_F MalFGK2, maltose, Escherichia coli [74] 99.9 1.60 × 10−20 207
3RLF_G MalFGK2, maltose, Escherichia coli [74] 99.9 1.20 × 10−21 209
4TQU_N AlgQ2M1M2SS, alginate, Sphingomonas sp. A1 [73] 99.8 2.20 × 10−20 207
1 Probability of being a true positive, taking into account a secondary structure score; 2 The number of columns
in the alignment.
Table A3. Structural homologs of BilEBSBD found by searching the PDB using the Dali server [48].
The scores given are from the best match (highest Z-score/lowest RMSD) of individual chain-to-chain
comparisons.
PDB ID Protein 1 Conformation in Crystal Structure Z-Score RMSD (Å) 2
1SW5 [33] AfProx open, no ligand 35.4 1.7 (267/270)
3MAM [32] AfProx open, ligand-bound (glycine betaine) 34.7 1.6 (267/270)
3O66 3 SaOpuCC open, no ligand 34.0 2 (269/272)
4NE4 3 AtProX open, no ligand 33.7 1.8 (268/281)
4ND9 3 AtProX open, no ligand 33.5 1.7 (267/280)
3PPN [54] BsOpuCC open, no ligand 33.4 2.4 (267/270)
4WEP [45] EcYehZ open, no ligand 33.0 2 (268/283)
3PPR [54] BsOpuCC closed, ligand-bound (ectoine) 30.6 3.9 (269/272)
3PPQ [54] BsOpuCC closed, ligand-bound (choline) 30.5 4.2 (269/271)
3PPP [54] BsOpuCC closed, ligand-bound (glycine betaine) 30.4 4.2 (269/272)
3PPO [54] BsOpuCC closed, ligand-bound (carnitine) 30.0 4.1 (269/272)
1SW2 [33] AfProX closed, ligand-bound (glycine betaine) 29.7 4.9 (267/270)
1SW1 [33] AfProX closed, ligand-bound (proline betaine) 29.3 4.8 (265/271)
1SW4 [33] AfProX closed, ligand-bound(trimethylammonium) 29.2 4.8 (268/270)
3R6U [53] BsOpuBC closed, ligand-bound (choline) 27.5 3.8 (247/272)
1 For full details, including organism names and UniProtKB accession numbers, see Table A1; 2 Numbers in
parentheses indicate the number of aligned residues/the total number of residues in the matched structure;
3 Deposited as part of the Protein Structure Initiative.
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Appendix B.
The amino acid sequence of the recombinant BilEBSBD protein is shown below. The N-terminal
tag, containing 10 histidine residues and a TEV protease cleavage site, is underlined. The remaining
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